1h Free Analyst Time
Global Artificial Blood Substitutes Market 2021-2025Speak directly to the analyst to clarify any post sales queries you may have.
The publisher has been monitoring the artificial blood substitutes market and it is poised to grow by $ 7.38 bn during 2021-2025, progressing at a CAGR of 23% during the forecast period. The reports on artificial blood substitutes market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing funding for product development, presence of large patient pool with intraoperative complications, and chronic blood donor shortage. In addition, increasing funding for product development is anticipated to boost the growth of the market as well.
The artificial blood substitutes market analysis includes product segment and geographical landscapes.
The artificial blood substitutes market is segmented as below:
By Product
- HBOC
- PFBOC
By Geographical Landscapes
- North America
- Europe
- Asia
- ROW
This study identifies the presence of large patient pool with intraoperative complications as one of the prime reasons driving the artificial blood substitutes market growth during the next few years.
The report on artificial blood substitutes market covers the following areas:
- Artificial blood substitutes market sizing
- Artificial blood substitutes market forecast
- Artificial blood substitutes market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading artificial blood substitutes market vendors that include Aurum Biosciences Ltd., Hemarina SA, Hemoglobin Oxygen Therapeutics LLC, KaloCyte Inc., NuvOx Pharma LLC, and SpheriTech Ltd. Also, the artificial blood substitutes market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.
Table of Contents
Executive Summary
Market Landscape
Market Sizing
Five Forces Analysis
Market Segmentation by Product
Geographic Landscape
Vendor Landscape
Vendor Analysis
Appendix
List of Exhibit
Executive Summary
The publisher recognizes the following companies as the key players in the global artificial blood substitutes market: Aurum Biosciences Ltd., Hemarina SA, Hemoglobin Oxygen Therapeutics LLC, KaloCyte Inc., NuvOx Pharma LLC, and SpheriTech Ltd.Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is presence of large patient pool with intraoperative complications.'
According to the report, one of the major drivers for this market is the increasing funding for product development.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned
A selection of companies mentioned in this report includes:
- Aurum Biosciences Ltd.
- Hemarina SA
- Hemoglobin Oxygen Therapeutics LLC
- KaloCyte Inc.
- NuvOx Pharma LLC
- SpheriTech Ltd.